R
Rusan Catar
Researcher at Charité
Publications - 48
Citations - 1637
Rusan Catar is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Receptor. The author has an hindex of 21, co-authored 32 publications receiving 1293 citations.
Papers
More filters
Journal ArticleDOI
Involvement of functional autoantibodies against vascular receptors in systemic sclerosis
Gabriela Riemekasten,Aurélie Philippe,Melanie Näther,Torsten Slowinski,Dominik N. Müller,Harald Heidecke,Marco Matucci-Cerinic,László Czirják,Ivo Lukitsch,Mike O Becker,A. Kill,Jacob M van Laar,Jacob M van Laar,Rusan Catar,Friedrich C. Luft,Gerd R Burmester,Björn Hegner,Duska Dragun +17 more
TL;DR: Functional autoimmunity directed at AT1R and ETAR is common in patients with SSc and could contribute to disease pathogenesis and may serve as biomarkers for risk assessment of disease progression.
Journal ArticleDOI
Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells.
Claudia Stielow,Rusan Catar,Gregor Muller,Kirstin Wingler,Peter Scheurer,Harald H.H.W. Schmidt,Henning Morawietz +6 more
TL;DR: It is concluded that VAS2870 could provide a novel strategy to inhibit the augmented endothelial superoxide anion formation in response to cardiovascular risk factors.
Book ChapterDOI
Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?
Guido Moll,Sven Geißler,Rusan Catar,Lech Ignatowicz,Martin J. Hoogduijn,Dirk Strunk,Karen Bieback,Olle Ringdén +7 more
TL;DR: It is argued that the differences of fresh and thawed MSCs are limited but significant, and recommended refocusing therapeutic MSC development on potency and safety assays with close resemblance of the clinical reality.
Journal ArticleDOI
Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua
Guido Moll,Guido Moll,Lech Ignatowicz,Rusan Catar,Christian Luecht,Behnam Sadeghi,Behnam Sadeghi,Osama A. Hamad,Philipp Jungebluth,Philipp Jungebluth,Duska Dragun,Artur Schmidtchen,Olle Ringdén,Olle Ringdén +13 more
TL;DR: In this paper, a safety follow-up on placenta-derived decidual stromal cells (DSCs), used as supportive immunomodulatory and regenerative therapy for patients with severe complications after allogeneic hematopoietic stem cell transplantation (HSCT), was presented.
Journal ArticleDOI
Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity
TL;DR: Better understanding of similarities and dissimilarities in HLA-DSA and distinct non-HLA antibody-related mechanisms of endothelial damage should facilitate discovery of common downstream signaling targets and pave the way for the development of endothelium-centered therapeutic strategies to accompany intensified immunosuppression and/or mechanical removal of antibodies.